Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Testosterone helps beard and axillary hair cells grow by releasing growth factors from dermal papilla cells.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Many acne patients have high androgen levels, which may lead to PCOD, but treatments like oral contraceptives and antiandrogens can help.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

Testosterone affects hair follicles differently across body sites, with beard hair follicles showing more activity of a specific enzyme and presence of androgen receptors compared to scalp hair.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Androgen hormones affect hair growth and oil production, influencing conditions like hair loss and acne.

A drug called cimetidine can help treat hair loss in women by blocking androgen receptors. However, it's not the first choice and needs more research.

The T-zone on the face has more androgen receptors and produces more oil than the U-zone.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

Testosterone increases hair follicle cell growth when beard or axillary skin cells are present together.

Androgenetic alopecia, or hair loss, is most common in people in their 30s, can start early, is often inherited, and may be influenced by factors like hormones and scalp health.

Androgens may contribute to keloid development, and hormone-targeting treatments could help.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

Androgen signaling reduces Wnt activity, affecting prostate stem cell growth.

Blocking androgens in male rats increased estrogen and made them more active.

Sper-12 nanoparticles may help treat hair loss by delivering siRNA to target androgen receptors.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.

Atypical male hair loss may not respond to usual treatments.

A new topical treatment for hair loss shows promise by targeting androgen receptors.

Personalized treatments for hair loss are becoming more effective by using genetic information.

A 15-year-old girl with no menstrual period was diagnosed with a genetic condition that makes her body unable to respond to male hormones, leading to female characteristics despite having male genetic makeup.

Androgen receptor degrader drugs may be a promising future treatment for hair loss.

Androgen affects oil production and hair growth in the skin.

Androgens like testosterone affect oil production and hair growth in skin and hair follicles.

Blocking androgens at birth reduces sexual motivation in male rats.

Blocking male hormones in baby rats improved memory and increased weight.

Finasteride is not effective for older women with hair loss.

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.